NASDAQ
3.98USD
-0.17 (-4.10%)
We have scored 20 news catalysts on Rezolute, Inc. (RZLT) over the past 12 months. The biggest single-day move next to one of them came Dec 12, 2025, when RZLT closed +28.6%: “Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating”. Coverage across the window leans negative (average ticker sentiment −0.92). Most of the impact sits in price momentum and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
383.2M
P/E
—
EPS
—
Beta
0.61
52W range
1.07-11.457
Day range
3.88–4.22
Open
4.20
Prev close
4.15
Volume
2M
Avg volume
1.7M
Dividend
0.00
IPO
2013-01-14
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Rezolute, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for RZLT: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
